Ms Chantelle Kay-Boom Controlled Drugs Coordinator, North West Controlled Drug Accountable Officer team, NHS England
Dr Lisa Byers Controlled Drug Accountable Officer (CDAO, Primary Care NI)
Aim
To outline the new process for GPs when reporting controlled drug-related issues and concerns that occur in the primary care general medical services (GMS) setting.
Learning outcomes
Having attended this webinar, you will be able to:
Describe the statutory responsibility of the Controlled Drugs Accountable Officer (CDAO) for primary care NI, in relation to the GMS setting and with regard to the CD Regulations NI 2009
Identify what constitutes a CD incident or concern
Understand the legal requirement to notify the CDAO of any concerns or adverse incidents involving CDs as part of a risk management process
Demonstrate how to use the new CD reporting tool
Outline how CD-related adverse incidents and concerns are managed once reported.
To provide healthcare professionals with the knowledge and skills to optimise medicines for older patients with multiple long-term conditions, using a structured approach to medication review.
Learning outcomes
Having attended this webinar, you will be able to:
Understand the implications of polypharmacy and the impact on patient safety, treatment effectiveness, and quality of life
Outline the 7-steps to appropriate polypharmacy framework as a structured approach to medication review
Adopt an evidence-based approach to prioritising deprescribing decisions, using appropriate resources and tools
Deprescribe, reduce or substitute inappropriate medicines through a structured medication review, involving the patient and their family members/carers.
To provide healthcare professionals with the knowledge and skills to optimise medicines for older patients with multiple long-term conditions, using a structured approach to medication review.
Learning outcomes
Having attended this webinar, you will be able to:
Understand the implications of polypharmacy and the impact on patient safety, treatment effectiveness, and quality of life
Outline the 7-steps to appropriate polypharmacy framework as a structured approach to medication review
Adopt an evidence-based approach to prioritising deprescribing decisions, using appropriate resources and tools
Deprescribe, reduce or substitute inappropriate medicines through a structured medication review, involving the patient and their family members/carers.
To provide healthcare professionals with the knowledge and skills to optimise medicines for older patients with multiple long-term conditions, using a structured approach to medication review.
Learning outcomes
Having attended this webinar, you will be able to:
Understand the implications of polypharmacy and the impact on patient safety, treatment effectiveness, and quality of life
Outline the 7-steps to appropriate polypharmacy framework as a structured approach to medication review
Adopt an evidence-based approach to prioritising deprescribing decisions, using appropriate resources and tools
Deprescribe, reduce or substitute inappropriate medicines through a structured medication review, involving the patient and their family members/carers.
To provide healthcare professionals with the knowledge and skills to optimise medicines for older patients with multiple long-term conditions, using a structured approach to medication review.
Learning outcomes
Having attended this webinar, you will be able to:
Understand the implications of polypharmacy and the impact on patient safety, treatment effectiveness, and quality of life
Outline the 7-steps to appropriate polypharmacy framework as a structured approach to medication review
Adopt an evidence-based approach to prioritising deprescribing decisions, using appropriate resources and tools
Deprescribe, reduce or substitute inappropriate medicines through a structured medication review, involving the patient and their family members/carers.